-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, *ST Weiming (002581.SZ) announced that the company plans to transfer 100% of the company's shares in Jilin Weiming Tianren Chinese Herbal Medicine Technology Development Co., Ltd. (hereinafter referred to as “Jilin Weiming”), “recombinant anti-TNFα all-human monoclonal antibody injection” pharmaceutical technology, and “injectable recombinant anti-CD25 human mouse chimeric monoclonal antibody” pharmaceutical technology (hereinafter referred to as “two pharmaceutical technologies”). The transaction is based on historical costs, and the initial public listing transfer price is not lower than the historical cost.

Zhitongcaijing·11/12/2026 11:41:35
Listen to the news
Zhitong Finance App News, *ST Weiming (002581.SZ) announced that the company plans to transfer 100% of the company's shares in Jilin Weiming Tianren Chinese Herbal Medicine Technology Development Co., Ltd. (hereinafter referred to as “Jilin Weiming”), “recombinant anti-TNFα all-human monoclonal antibody injection” pharmaceutical technology, and “injectable recombinant anti-CD25 human mouse chimeric monoclonal antibody” pharmaceutical technology (hereinafter referred to as “two pharmaceutical technologies”). The transaction is based on historical costs, and the initial public listing transfer price is not lower than the historical cost.